Status:
RECRUITING
Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
Lead Sponsor:
Hospital Italiano de Buenos Aires
Conditions:
Hypertension, Pulmonary Arterial
Eligibility:
All Genders
17+ years
Brief Summary
The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.
Detailed Description
The Institutional Registry of Pulmonary Hypertension includes patients prospectively with incident pulmonary hypertension type I. It also includes prevalent cases from our HMO who had diagnosis prior ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \>15 mmHg and pulmonary vascular resistance (PVR) \>2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
- Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
- Aged ≥18 years at the index date.
- Exclusion Criteria History of lung transplantation surgery previously the baseline period
Exclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2031
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01501838
Start Date
January 1 2017
End Date
June 1 2031
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires, Argentina, 1181